Boehringer Ingelheim Pharmaceuticals Inc. Earns CEO Cancer Gold Standard Accreditation

16-12-2013 Business Wire HealthComments (0)

Boehringer IngelheimPharmaceutical

Boehringer Ingelheim Pharmaceuticals earns CEO Cancer Gold Standard for efforts to reduce cancer risk by promoting healthy choices, encouraging early detection and ensuring access to quality care.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top